REOPRO DIN 02216973
Health Canada record
| Active ingredient(s) | ABCIXIMAB 2 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION; SCHEDULE D |
| Class | Human |
| ATC | B01AC13 ABCIXIMAB |
| Original market date | 30-Oct-1996 |
| Current status date | 14-Jun-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Janssen Inc — licence 100239, currently licensed, last inspection rating C (2026-03-09).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 13062 | 2012-02-27 | New Drug Submission (NDS) | Manufacturer name change |
| 12485 | 2011-06-27 | New Drug Submission (NDS) | Manufacturer name change |
| 4175 | 1996-07-04 | New Drug Submission (NDS) |